A Study of a New Potential Treatment for Multiple Myeloma
Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!
a study on Multiple Myeloma
- for people ages 18 years and up (full criteria)
- at Sacramento, California and other locations
- study startedestimated completion
Multiple Myeloma, Anti-CD38 A2 DAR-T Cells, Relapsed or Refractory Multiple Myeloma, Plasma Cell Neoplasms, STI-1492
- accepting new patients
- Start Date
- Completion Date
- Sorrento Therapeutics, Inc.
- Sign up for this study
- Phase 1 Multiple Myeloma Research Study
- Study Type
- Expecting 54 study participants
- Last Updated